Myb proteins: Angels and demons in normal and transformed cells

Frontiers in Bioscience

Volumn 16, Issue 3, 2011, Pages 1109-1131

  Zhou, Ye ^a   Ness, Scott A ^a,b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle; Hematopoiesis; Myb; Oncogene; Post translational modifications; Protein protein interactions; Review; SANT domain; SND1; Stem cells; Transcription; Transformation

Indexed keywords

CELL CYCLE PROTEIN; DNA BINDING PROTEIN; MICRORNA; MYBL1 PROTEIN, HUMAN; MYBL2 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN C MYB; TRANSACTIVATOR PROTEIN; WNT PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECT; GENETICS; HUMAN; LEUKEMIA; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; VIRUS CELL TRANSFORMATION;

ALTERNATIVE SPLICING; ANIMALS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, VIRAL; DNA-BINDING PROTEINS; HUMANS; LEUKEMIA; MICRORNAS; NEOPLASMS; ONCOGENE PROTEINS V-MYB; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYB; SIGNAL TRANSDUCTION; STEM CELLS; TRANS-ACTIVATORS; WNT PROTEINS;

EID: 79955043846     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3738     Document Type: Article

References (212)

1. KH Klempnauer, TJ Gonda and JM Bishop: Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. Cell 31, 453-463 (1982) (Pubitemid 13178869)
2. TJ Gonda and JM Bishop: Structure and transcription of the cellular homolog (c-myb) of the avian myeloblastosis virus transforming gene (v-myb). J Virol 46, 212-220 (1983) (Pubitemid 13161261)
3. PG Pelicci, L Lanfrancone, MD Brathwaite, SR Wolman and R Dalla-Favera: Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia. Science 224, 1117-1121 (1984) (Pubitemid 14106391)
4. P Kauraniemi, I Hedenfalk, K Persson, DJ Duggan, M Tanner, O Johannsson, H Olsson, JM Trent, J Isola and A Borg: MYB oncogene amplification in hereditary BRCA1 breast cancer. Cancer Res 60, 5323-5328 (2000)
5. Y Drabsch, H Hugo, R Zhang, DH Dowhan, YR Miao, AM Gewirtz, SC Barry, RG Ramsay and TJ Gonda: Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells. Proc Natl Acad Sci U S A 104, 13762-13767 (2007) (Pubitemid 350003394)
6. M Persson, Y Andren, J Mark, HM Horlings, F Persson and G Stenman: Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A 106, 18740-18744 (2009)
7. G Torelli, D Venturelli, A Colo, C Zanni, L Selleri, L Moretti, B Calabretta and U Torelli: Expression of c-myb protooncogene and other cell cycle-related genes in normal and neoplastic human colonic mucosa. Cancer Res 47, 5266-5269 (1987) (Pubitemid 17152930)
8. RG Ramsay, MA Thompson, JA Hayman, G Reid, TJ Gonda and RH Whitehead: Myb expression is higher in malignant human colonic carcinoma and premalignant adenomatous polyps than in normal mucosa. Cell Growth Differ 3, 723-730 (1992)
9. MA Thompson, R Flegg, EH Westin and RG Ramsay: Microsatellite deletions in the c-myb transcriptional attenuator region associated with over-expression in colon tumour cell lines. Oncogene 14, 1715-1723 (1997) (Pubitemid 27198944)
10. H Hugo, A Cures, N Suraweera, Y Drabsch, D Purcell, T Mantamadiotis, W Phillips, A Dobrovic, G Zupi, TJ Gonda, B Iacopetta and RG Ramsay: Mutations in the MYB intron I regulatory sequence increase transcription in colon cancers. Genes Chromosomes Cancer 45, 1143-1154 (2006) (Pubitemid 44763442)
11. C Wallrapp, F Muller-Pillasch, S Solinas-Toldo, P Lichter, H Friess, M Buchler, T Fink, G Adler and TM Gress: Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene. Cancer Res 57, 3135-3139 (1997) (Pubitemid 27351725)
12. C Welter, W Henn, B Theisinger, H Fischer, KD Zang and N Blin: The cellular myb oncogene is amplified, rearranged and activated in human glioblastoma cell lines. Cancer Lett 52, 57-62 (1990) (Pubitemid 20185577)
13. HH Engelhard: Antisense Oligodeoxynucleotide Technology: Potential Use for the Treatment of Malignant Brain Tumors. Cancer Control 5, 163-170 (1998) (Pubitemid 28178237)
14. P Dasgupta, AJ Linnenbach, AJ Giaccia, TD Stamato and EP Reddy: Molecular cloning of the breakpoint region on chromosome 6 in cutaneous malignant melanoma: evidence for deletion in the c-myb locus and translocation of a segment of chromosome 12. Oncogene 4, 1201-1205 (1989) (Pubitemid 19246963)
15. MJ Walker, E Silliman, MA Dayton and JC Lang: The expression of C-myb in human metastatic melanoma cell lines and specimens. Anticancer Res 18, 1129-1135 (1998) (Pubitemid 28239652)
16. E Clappier, W Cuccuini, A Kalota, A Crinquette, JM Cayuela, WA Dik, AW Langerak, B Montpellier, B Nadel, P Walrafen, O Delattre, A Aurias, T Leblanc, H Dombret, AM Gewirtz, A Baruchel, F Sigaux and J Soulier: The CMYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (TALL), the translocation defining a new T-ALL subtype in very young children. Blood 110, 1251-1261 (2007) (Pubitemid 47281423)
17. J O'Neil, J Tchinda, A Gutierrez, L Moreau, RS Maser, KK Wong, W Li, K McKenna, XS Liu, B Feng, D Neuberg, L Silverman, DJ DeAngelo, JL Kutok, R Rothstein, RA DePinho, L Chin, C Lee and AT Look: Alu elements mediate MYB gene tandem duplication in human T-ALL. J Exp Med 204, 3059-3066 (2007)
18. I Lahortiga, K De Keersmaecker, P Van Vlierberghe, C Graux, B Cauwelier, F Lambert, N Mentens, HB Beverloo, R Pieters, F Speleman, MD Odero, M Bauters, G Froyen, P Marynen, P Vandenberghe, I Wlodarska, JP Meijerink and J Cools: Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nat Genet 39, 593-595 (2007) (Pubitemid 46676109)
19. JP O'Rourke and SA Ness: Alternative RNA splicing produces multiple forms of c-Myb with unique transcriptional activities. Mol Cell Biol 28, 2091-2101 (2008) (Pubitemid 351342638)
20. N Poenitz, J Simon-Ackermann, A Gratchev, M Qadoumi, CD Klemke, R Stadler, A Kremer, M Radenhausen, U Henke, C Assaf, J Utikal, S Goerdt and E Dippel: Overexpression of c-myb in leukaemic and nonleukaemic variants of cutaneous T-cell lymphoma. Dermatology 211, 84-92 (2005) (Pubitemid 41160240)
21. AM Gewirtz and B Calabretta: A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science 242, 1303-1306 (1988) (Pubitemid 19008061)
22. ML Mucenski, K McLain, AB Kier, SH Swerdlow, CM Schreiner, TA Miller, DW Pietryga, WJJ Scott and SS Potter: A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65, 677-689 (1991)
23. MG Moscovici, P Jurdic, J Samarut, L Gazzolo, CV Mura and C Moscovici: Characterization of the hemopoietic target cells for the avian leukemia virus E26. Virology 129, 65-78 (1983) (Pubitemid 13018140)
24. K Radke, H Beug, S Kornfeld and T Graf: Transformation of both erythroid and myeloid cells by E26, an avian leukemia virus that contains the myb gene. Cell 31, 643-653 (1982) (Pubitemid 13223948)
25. L Frykberg, T Metz, G Brady, M Introna, H Beug, B Vennstrom and T Graf: A point mutation in the DNA binding domain of the v-myb oncogene of E26 virus confers temperature sensitivity for transformation of myelomonocytic cells. Oncogene Res 3, 313-322 (1988) (Pubitemid 19049215)
26. SA Ness, A Marknell and T Graf: The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell 59, 1115-1125 (1989) (Pubitemid 20024622)
27. M Introna, J Golay, J Frampton, T Nakano, SA Ness and T Graf: Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene. Cell 63, 1289-1297 (1990)
28. M Suhasini and RB Pilz: Transcriptional elongation of c-myb is regulated by NF-kappaB (p50/RelB). Oncogene 18, 7360-7369 (1999) (Pubitemid 30032117)
29. RJ Watson: A transcriptional arrest mechanism involved in controlling constitutive levels of mouse c-myb mRNA. Oncogene 2, 267-272 (1988) (Pubitemid 18085306)
30. EY Chung, M Dews, D Cozma, D Yu, EA Wentzel, TC Chang, JM Schelter, MA Cleary, JT Mendell and A Thomas-Tikhonenko: c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster. Cancer Biol Ther 7, 1758-1764 (2008)
31. YC Lin, MW Kuo, J Yu, HH Kuo, RJ Lin, WL Lo and AL Yu: c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development. Mol Biol Evol 25, 2189-2198 (2008)
32. J Lu, S Guo, BL Ebert, H Zhang, X Peng, J Bosco, J Pretz, R Schlanger, JY Wang, RH Mak, DM Dombkowski, FI Preffer, DT Scadden and TR Golub: MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell 14, 843-853 (2008) (Pubitemid 351757199)
33. C Xiao, DP Calado, G Galler, TH Thai, HC Patterson, J Wang, N Rajewsky, TP Bender and K Rajewsky: MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131, 146-159 (2007) (Pubitemid 47498525)
34. H Zhao, A Kalota, S Jin and AM Gewirtz: The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells. Blood 113, 505-516 (2009)
35. H Biedenkapp, U Borgmeyer, AE Sippel and K-H Klempnauer: Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature 335, 835-837 (1988)
36. F Liu, W Lei, JP O'Rourke and SA Ness: Oncogenic mutations cause dramatic, qualitative changes in the transcriptional activity of c-Myb. Oncogene 25, 795-805 (2006) (Pubitemid 43214705)
37. JJ Rushton, LM Davis, W Lei, X Mo, A Leutz and SA Ness: Distinct changes in gene expression induced by A-Myb, B-Myb and c-Myb proteins. Oncogene 22, 308-313 (2003) (Pubitemid 36174188)
38. H Sakamoto, G Dai, K Tsujino, K Hashimoto, X Huang, T Fujimoto, M Mucenski, J Frampton and M Ogawa: Proper levels of c-Myb are discretely defined at distinct steps of hematopoietic cell development. Blood 108, 896-903 (2006) (Pubitemid 44154622)
39. KT Greig, CA de Graaf, JM Murphy, MR Carpinelli, SH Pang, J Frampton, BT Kile, DJ Hilton and SL Nutt: Critical roles for c-Myb in lymphoid priming and early Bcell development. Blood 115, 2796-2805 (2010)
40. T Hu, A Simmons, J Yuan, TP Bender and J Alberola- Ila: The transcription factor c-Myb primes CD4(+)CD8(+) immature thymocytes for selection into the iNKT lineage. Nat Immunol (2010)
41. J Yuan, RB Crittenden and TP Bender: c-Myb promotes the survival of CD4+CD8+ double-positive thymocytes through upregulation of Bcl-xL. J Immunol 184, 2793-2804 (2010)
42. P Garcia, M Clarke, A Vegiopoulos, O Berlanga, A Camelo, M Lorvellec and J Frampton: Reduced c-Myb activity compromises HSCs and leads to a myeloproliferation with a novel stem cell basis. EMBO J 28, 1492-1504 (2009)
43. P Ferrao, TJ Gonda and LK Ashman: Expression of constitutively activated human c-Kit in Myb transformed early myeloid cells leads to factor independence, histiocytic differentiation, and tumorigenicity. Blood 90, 4539-4552 (1997) (Pubitemid 27508460)
44. V Karafiat, M Dvorakova, P Pajer, V Cermak and M Dvorak: Melanocyte fate in neural crest is triggered by Myb proteins through activation of c-kit. Cell Mol Life Sci 64, 2975-2984 (2007) (Pubitemid 351152252)
45. MZ Ratajczak, D Perrotti, P Melotti, M Powzaniuk, B Calabretta, K Onodera, DA Kregenow, B Machalinski and AM Gewirtz: Myb and ets proteins are candidate regulators of c-kit expression in human hematopoietic cells. Blood 91, 1934-1946 (1998) (Pubitemid 28185494)
46. A Vegiopoulos, P Garcia, N Emambokus and J Frampton: Coordination of erythropoiesis by the transcription factor c-Myb. Blood 107, 4703-4710 (2006) (Pubitemid 43882618)
47. J Frampton, T Ramqvist and T Graf: v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. Genes Dev 10, 2720-2731 (1996) (Pubitemid 26384492)
48. MA Thompson, MA Rosenthal, SL Ellis, AJ Friend, MI Zorbas, RH Whitehead and RG Ramsay: c-Myb downregulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression. Cancer Res 58, 5168-5175 (1998) (Pubitemid 28521178)
49. XY He, VP Antao, D Basila, JC Marx and BR Davis: Isolation and molecular characterization of the human CD34 gene. Blood 79, 2296-2302 (1992)
50. C Hernandez-Munain and MS Krangel: Regulation of the T-cell receptor delta enhancer by functional cooperation between c-Myb and core-binding factors. Mol Cell Biol 14, 473-483 (1994)
51. DH Ku, SC Wen, A Engelhard, NC Nicolaides, KE Lipson, TA Marino and B Calabretta: c-myb transactivates cdc2 expression via Myb binding sites in the 5′-flanking region of the human cdc2 gene. J Biol Chem 268, 2255-2259 (1993) (Pubitemid 23033642)
52. Y Nakata, S Shetzline, C Sakashita, A Kalota, R Rallapalli, SI Rudnick, Y Zhang, SG Emerson and AM Gewirtz: c-Myb contributes to G2/M cell cycle transition in human hematopoietic cells by direct regulation of cyclin B1 expression. Mol Cell Biol 27, 2048-2058 (2007) (Pubitemid 46418463)
53. H Nakagoshi, C Kanei-Ishii, T Sawazaki, G Mizuguchi and S Ishii: Transcriptional activation of the c-myc gene by the c-myb and B-myb gene products. Oncogene 7, 1233-1240 (1992)
54. J Sitzmann, K Noben-Trauth and KH Klempnauer: Expression of mouse c-myb during embryonic development. Oncogene 11, 2273-2279 (1995) (Pubitemid 26008403)
55. M Zorbas, C Sicurella, I Bertoncello, D Venter, S Ellis, ML Mucenski and RG Ramsay: c-Myb is critical for murine colon development. Oncogene 18, 5821-5830 (1999) (Pubitemid 29507436)
56. J Malaterre, M Carpinelli, M Ernst, W Alexander, M Cooke, S Sutton, S Dworkin, JK Heath, J Frampton, G McArthur, H Clevers, D Hilton, T Mantamadiotis and RG Ramsay: c-Myb is required for progenitor cell homeostasis in colonic crypts. Proc Natl Acad Sci U S A 104, 3829-3834 (2007) (Pubitemid 47181539)
57. J Malaterre, T Mantamadiotis, S Dworkin, S Lightowler, Q Yang, MI Ransome, AM Turnley, NR Nichols, NR Emambokus, J Frampton and RG Ramsay: c- Myb is required for neural progenitor cell proliferation and maintenance of the neural stem cell niche in adult brain. Stem Cells 26, 173-181 (2008)
58. SA Ness: The Myb oncoprotein: regulating a regulator. Biochim Biophys Acta 1288, F123-39 (1996) (Pubitemid 27006534)
59. JJ Rushton and SA Ness: The Conserved DNA Binding Domain Mediates Similar Regulatory Interactions for AMyb, B-Myb, and c-Myb Transcription Factors. Blood Cells Mol Dis 27, 459-63. (2001) (Pubitemid 32547844)
60. Y Tanaka, NP Patestos, T Maekawa and S Ishii: B-myb is required for inner cell mass formation at an early stage of development. J Biol Chem 274, 28067-2870. (1999)
61. A Toscani, RV Mettus, R Coupland, H Simpkins, J Litvin, J Orth, KS Hatton and EP Reddy: Arrest of spermatogenesis and defective breast development in mice lacking A-myb. Nature 386, 713-717 (1997) (Pubitemid 27193491)
62. LC Hodges, JD Cook, EK Lobenhofer, L Li, L Bennett, PR Bushel, CM Aldaz, CA Afshari and CL Walker: Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells. Mol Cancer Res 1, 300-311 (2003) (Pubitemid 36292615)
63. CWB Peters, AE Sippel, M Vingron and K-H Klempnauer: Drosophila and vertebrate myb proteins share two conserved regions, one of which functions as a DNA-binding domain. EMBO J 6, 3085-3090 (1987)
64. JR Manak, N Mitiku and JS Lipsick: Mutation of the Drosophila homologue of the Myb protooncogene causes genomic instability. Proc Natl Acad Sci U S A 99, 7438-7443 (2002) (Pubitemid 34568709)
65. JR Manak, H Wen, T Van, L Andrejka and JS Lipsick: Loss of Drosophila Myb interrupts the progression of chromosome condensation. Nat Cell Biol 9, 581-587 (2007) (Pubitemid 46696540)
66. B Perbal, F Reinisch-Deschamps, C Kryceve- Martinerie, J Soret, F Sor, M Mechali and J Crochet: Transforming potential of the v-myb oncogene from avian myeloblastosis virus: alterations in the oncogene product may reveal a new target specificity. Biochimie 68, 969-980 (1986) (Pubitemid 16041564)
67. CE Ibanez and JS Lipsick: trans activation of gene expression by v-myb. Mol Cell Biol 10, 2285-2293 (1990)
68. RE Aurigemma, DG Blair and SK Ruscetti: Transactivation of Erythroid Transcription Factor GATA-1 by a myb-ets-Containing Retrovirus. J Virol 66, 3056-3061 (1992)
69. J Davies, P Badiani and K Weston: Cooperation ofMyb and Myc proteins in T cell lymphomagenesis. Oncogene 18, 3643-3647 (1999) (Pubitemid 29322389)
70. JW Dubendorff, LJ Whittaker, JT Eltman and JS Lipsick: Carboxy-terminal elements of c-Myb negatively regulate transcriptional activation in cis and in trans. Genes Dev 6, 2524-2535 (1992) (Pubitemid 23052881)
71. P Ferrao, EM Macmillan, LK Ashman and TJ Gonda: Enforced expression of full length c-Myb leads to density-dependent transformation of murine haemopoietic cells. Oncogene 11, 1631-1638 (1995)
72. SL Fu and JS Lipsick: Constitutive expression of full-length c-Myb transforms avian cells characteristic of both the monocytic and granulocytic lineages. Cell Growth Differ 8, 35-45 (1997) (Pubitemid 27030236)
73. Y Furuta, S Aizawa, Y Suda, Y Ikawa, H Nakasgoshi, Y Nishina and S Ishii: Degeneration of skeletal and cardiac muscles in c-myb transgenic mice. Transgenic Res 2, 199-207 (1993)
74. TJ Gonda, C Buckmaster and RG Ramsay: Activation of c-myb by carboxy-terminal truncation: relationship to transformation of murine haemopoietic cells in vitro. EMBO J 8, 1777-1783 (1989) (Pubitemid 19273994)
75. TJ Gonda, S Cory, P Sobieszczuk, D Holtzman and JM Adams: Generation of altered transcripts by retroviral insertion within the c-myb gene in two murine monocytic leukemias. J Virol 61, 2754-2763 (1987) (Pubitemid 17143435)
76. R Mukhopadhyaya and L Wolff: New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation. J Virol 66, 6035-6044 (1992)
77. K Nason-Burchenal and L Wolff: Activation of c-myb is an early bone-marrow event in a murine model for acute promonocytic leukemia. Proc Natl Acad Sci U S A 90, 1619-1623 (1993) (Pubitemid 23058225)
78. W Lei, JJ Rushton, LM Davis, F Liu and SA Ness: Positive and negative determinants of target gene specificity in Myb transcription factors. J Biol Chem 279, 29519-29527 (2004) (Pubitemid 38915832)
79. MR Kanter, RE Smith and WS Hayward: Rapid induction of B-cell lymphomas: insertional activation of cmyb by avian leukosis virus. J Virol 62, 1423-1432 (1988) (Pubitemid 18082958)
80. W Jiang, MR Kanter, I Dunkel, RG Ramsay, KL Beemon and WS Hayward: Minimal truncation of the cmyb gene product in rapid-onset B-cell lymphoma. J Virol 71, 6526-6533 (1997) (Pubitemid 27355308)
81. O Burk and KH Klempnauer: Myb and Ets transcription factors cooperate at the myb-inducible promoter of the tom- 1 gene. Biochim Biophys Acta 1446, 243-252 (1999) (Pubitemid 29401897)
82. PW Dini and JS Lipsick: Oncogenic truncation of the first repeat of c-Myb decreases DNA binding in vitro and in vivo. Mol Cell Biol 13, 7334-7348 (1993) (Pubitemid 23354257)
83. B Ganter, S Fu and JS Lipsick: D-type cyclins repress transcriptional activation by the v-Myb but not the c-Myb DNA-binding domain. EMBO J 17, 255-268 (1998) (Pubitemid 28041066)
84. M Oelgeschlager, E Kowenz-Leutz, S Schreek, A Leutz and B Luscher: Tumorigenic N-terminal deletions of c- Myb modulate DNA binding, transactivation, and cooperativity with C/EBP. Oncogene 20, 7420-7424 (2001) (Pubitemid 33078213)
85. B Luscher, E Christenson, DW Litchfield, EG Krebs and RN Eisenman: Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation. Nature 344, 517-522 (1990)
86. SM Jacobs, KM Gorse and EH Westin: Identification of a second promoter in the human c-myb proto-oncogene. Oncogene 9, 227-235 (1994) (Pubitemid 24020954)
87. M Vellard, J Soret, E Viegas-Pequignot, F Galibert, VCNguyen, B Dutrillaux and B Perbal: C-myb protooncogene: evidence for intermolecular recombination of coding sequences. Oncogene 6, 505-514 (1991) (Pubitemid 21924113)
88. M Vellard, A Sureau, J Soret, C Martinerie and B Perbal: A potential splicing factor is encoded by the opposite strand of the trans-spliced c-myb exon. Proc Natl Acad Sci U S A 89, 2511-2515 (1992)
89. J Soret, M Vellard, C Martinerie and B Perbal: Organization of 5′-proximal c-myb exons in chicken DNA. Implications for c-myb tissue-specific transcription. FEBS Lett 232, 227-234 (1988)
90. AB Dash, FC Orrico and SA Ness: The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb. Genes Dev 10, 1858-1869 (1996) (Pubitemid 26281681)
91. A Kiewitz and H Wolfes: Mapping of proteinprotein interactions between c-myb and its coactivator CBP by a new phage display technique. FEBS Lett 415, 258-262 (1997) (Pubitemid 27451944)
92. N Aziz, J Wu, JW Dubendorff, JS Lipsick, TW Sturgill and TP Bender: c-Myb and v-Myb are differentially phosphorylated by p42mapk in vitro. Oncogene 8, 2259-2265 (1993) (Pubitemid 23226961)
93. J Bies, J Markus and L Wolff: Covalent attachment of the SUMO-1 protein to the negative regulatory domain of the c-Myb transcription factor modifies its stability and transactivation capacity. J Biol Chem 277, 8999-9009 (2002) (Pubitemid 34952972)
94. E Pani, M Menigatti, S Schubert, D Hess, B Gerrits, KH Klempnauer and S Ferrari: Pin1 interacts with c-Myb in a phosphorylation-dependent manner and regulates its transactivation activity. Biochim Biophys Acta 1783, 1121-1128 (2008)
95. P Lienard, M Riviere, P Van Vooren, C Szpirer and J Szpirer: Assignment of SND1, the gene encoding coactivator p100, to human chromosome 7q31.3 and rat chromosome 4q23 by in situ hybridization. Cytogenet Cell Genet 90, 253-254 (2000) (Pubitemid 32008774)
96. MK Broadhurst, RS Lee, S Hawkins and TT Wheeler: The p100 EBNA-2 coactivator: a highly conserved protein found in a range of exocrine and endocrine cells and tissues in cattle. Biochim Biophys Acta 1681, 126-133 (2005) (Pubitemid 41071385)
97. X Tong, R Drapkin, R Yalamanchili, G Mosialos and E Kieff: The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE. Mol Cell Biol 15, 4735-4744 (1995)
98. DS Schwarz, Y Tomari and PD Zamore: The RNAinduced silencing complex is a Mg2+-dependent endonuclease. Curr Biol 14, 787-791 (2004) (Pubitemid 38583713)
99. AA Caudy, RF Ketting, SM Hammond, AM Denli, AM Bathoorn, BB Tops, JM Silva, MM Myers, GJ Hannon and RH Plasterk: A micrococcal nuclease homologue in RNAi effector complexes. Nature 425, 411-414 (2003) (Pubitemid 37187271)
100. W Yang, TP Chendrimada, Q Wang, M Higuchi, PH Seeburg, R Shiekhattar and K Nishikura: Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol 13, 13-21 (2006) (Pubitemid 43049397)
101. AD Scadden: The RISC subunit Tudor-SN binds to hyper-edited double-stranded RNA and promotes its cleavage. Nat Struct Mol Biol 12, 489-496 (2005) (Pubitemid 43085878)
102. JD Leverson, PJ Koskinen, FC Orrico, EM Rainio, KJ Jalkanen, AB Dash, RN Eisenman and SA Ness: Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol Cell 2, 417-425 (1998) (Pubitemid 128381294)
103. LM Winn, W Lei and SA Ness: Pim-1 phosphorylates the DNA binding domain of c-Myb. Cell Cycle 2, 258-262 (2003)
104. T Nomura, J Tanikawa, H Akimaru, C Kanei-Ishii, E Ichikawa-Iwata, MM Khan, H Ito and S Ishii: Oncogenic activation of c-Myb correlates with a loss of negative regulation by TIF1beta and Ski. J Biol Chem 279, 16715-16726 (2004) (Pubitemid 38509374)
105. DR Pattabiraman, J Sun, DH Dowhan, S Ishii and TJ Gonda: Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability. Mol Cancer Res 7, 1477-1486 (2009)
106. JD Leverson and SA Ness: Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism. Mol Cell 1, 203-211 (1998) (Pubitemid 128378661)
107. J Bies and L Wolff: Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway. Oncogene 14, 203-212 (1997) (Pubitemid 27068306)
108. J Bies, V Nazarov and L Wolff: Identification of protein instability determinants in the carboxy-terminal region of c-Myb removed as a result of retroviral integration in murine monocytic leukemias. J Virol 73, 2038-2044 (1999) (Pubitemid 29098106)
109. YL Hu, RG Ramsay, C Kanei-Ishii, S Ishii and TJ Gonda: Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain. Oncogene 6, 1549-1553 (1991) (Pubitemid 21924256)
110. FA Grasser, T Graf and JS Lipsick: Protein truncation is required for the activation of the c-myb proto-oncogene. Mol Cell Biol 11, 3987-3996 (1991) (Pubitemid 21895788)
111. AK Molvaersmyr, T Saether, S Gilfillan, PI Lorenzo, H Kvaloy, V Matre and OS Gabrielsen: A SUMOregulated activation function controls synergy of c-Myb through a repressor-activator switch leading to differential p300 recruitment. Nucleic Acids Res (2010)
112. C Kanei-Ishii, J Ninomiya-Tsuji, J Tanikawa, T Nomura, T Ishitani, S Kishida, K Kokura, T Kurahashi, E Ichikawa-Iwata, Y Kim, K Matsumoto and S Ishii: Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK. Genes Dev 18, 816-829 (2004) (Pubitemid 38480893)
113. C Kanei-Ishii, T Nomura, T Takagi, N Watanabe, KI Nakayama and S Ishii: Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation. J Biol Chem 283, 30540-30548 (2008)
114. C Kanei-Ishii, T Nomura, J Tanikawa, E Ichikawa- Iwata and S Ishii: Differential sensitivity of v-Myb and c- Myb to Wnt-1-induced protein degradation. J Biol Chem 279, 44582-44589 (2004) (Pubitemid 39430865)
115. K Weston: Extension of the DNA binding consensus of the chicken c-Myb and v-Myb proteins. Nucleic Acids Res 20, 3043-3049 (1992)
116. B Ganter and JS Lipsick: Myb and oncogenesis. Adv Cancer Res 76, 21-60 (1999) (Pubitemid 29190880)
117. H Sakura, C Kanei-Ishii, T Nagase, H Nakagoshi, TJ Gonda and S Ishii: Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene. Proc Natl Acad Sci U S A 86, 5758-5762 (1989) (Pubitemid 19217533)
118. K Weston and JM Bishop: Transcriptional activation by the v-myb oncogene and its cellular progenitor, c-myb. Cell 58, 85-93 (1989) (Pubitemid 19180081)
119. J Tanikawa, T Yasukawa, M Enari, K Ogata, Y Nishimura, S Ishii and A Sarai: Recognition of specific DNA sequences by the c-myb protooncogene product: role of three repeat units in the DNA-binding domain. Proc Natl Acad Sci U S A 90, 9320-9324 (1993) (Pubitemid 23315775)
120. K Ogata, S Morikawa, H Nakamura, A Sekikawa, T Inoue, H Kanai, A Sarai, S Ishii and Y Nishimura: Solution structure of a specific DNA complex of the Myb DNAbinding domain with cooperative recognition helices. Cell 79, 639-648 (1994) (Pubitemid 24363807)
121. PW Dini, JT Eltman and JS Lipsick: Mutations in the DNA-binding and transcriptional activation domains of v- Myb cooperate in transformation. J Virol 69, 2515-2524 (1995)
122. KB Andersson, E Kowenz-Leutz, EM Brendeford, AH Tygsett, A Leutz and OS Gabrielsen: Phosphorylationdependent down-regulation of c-Myb DNA binding is abrogated by a point mutation in the v-myb oncogene. J Biol Chem 278, 3816-3824 (2003) (Pubitemid 36801109)
123. X Mo, E Kowenz-Leutz, Y Laumonnier, H Xu and A Leutz: Histone H3 tail positioning and acetylation by the c- Myb but not the v-Myb DNA-binding SANT domain. Genes Dev 19, 2447-2457 (2005) (Pubitemid 41483692)
124. AM Baker, Q Fu, W Hayward, SM Lindsay and TM Fletcher: The Myb/SANT domain of the telomere-binding protein TRF2 alters chromatin structure. Nucleic Acids Res37, 5019-5031 (2009)
125. LA Boyer, MR Langer, KA Crowley, S Tan, JM Denu and CL Peterson: Essential role for the SANT domain in the functioning of multiple chromatin remodeling enzymes. Mol Cell 10, 935-942 (2002) (Pubitemid 35335647)
126. G Mizuguchi, H Nakagoshi, T Nagase, N Nomura, T Date, Y Ueno and S Ishii: DNA binding activity and transcriptional activator function of the human B-myb protein compared with c-MYB. J Biol Chem 265, 9280-9284 (1990)
127. XP Ma and B Calabretta: DNA binding and transactivation activity of A-myb, a c-myb-related gene. Cancer Res 54, 6512-6516 (1994)
128. M Bessa, M Joaquin, F Tavner, MK Saville and RJ Watson: Regulation of the cell cycle by B-Myb. Blood Cells Mol Dis 27, 416-421 (2001) (Pubitemid 32547838)
129. J Golay, V Broccoli, GM Borleri, E Erba, M Faretta, L Basilico, GG Ying, G Piccinini, LH Shapiro, J Lovric, M Nawrath, K Molling, A Rambaldi and M Introna: Redundant functions of B-Myb and c-Myb in differentiating myeloid cells. Cell Growth Differ 8, 1305-1316 (1997) (Pubitemid 28008727)
130. J Golay, G Cusmano and M Introna: Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes. J Immunol 149, 300-308 (1992)
131. G Raschella, V Cesi, R Amendola, A Negroni, B Tanno, P Altavista, GP Tonini, B De Bernardi and B Calabretta: Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification. Cancer Res 59, 3365-3368 (1999) (Pubitemid 29334493)
132. AR Thorner, KA Hoadley, JS Parker, S Winkel, RC Millikan and CM Perou: In vitro and in vivo analysis of BMyb in basal-like breast cancer. Oncogene 28, 742-751 (2009)
133. F Schmit, M Korenjak, M Mannefeld, K Schmitt, C Franke, B von Eyss, S Gagrica, F Hanel, A Brehm and S Gaubatz: LINC, a human complex that is related to pRBcontaining complexes in invertebrates regulates the expression of G2/M genes. Cell Cycle 6, 1903-1913 (2007) (Pubitemid 47327909)
134. J Golay, V Broccoli, G Lamorte, C Bifulco, C Parravicini, A Pizzey, NS Thomas, D Delia, P Ferrauti, D Vitolo and M Introna: The A-Myb transcription factor is a marker of centroblasts in vivo. J Immunol 160, 2786-2793 (1998) (Pubitemid 28136732)
135. J Golay, L Loffarelli, M Luppi, M Castellano and M Introna: The human A-myb protein is a strong activator of transcription. Oncogene 9, 2469-2479 (1994) (Pubitemid 24254022)
136. SE DeRocco, R Iozzo, XP Ma, R Schwarting, D Peterson and B Calabretta: Ectopic expression of A-myb in transgenic mice causes follicular hyperplasia and enhanced B lymphocyte proliferation. Proc Natl Acad Sci U S A 94, 3240-3244 (1997) (Pubitemid 27157295)
137. J Golay, M Luppi, S Songia, C Palvarini, L Lombardi, A Aiello, D Delia, K Lam, DH Crawford, A Biondi, T Barbui, A Rambaldi and M Introna: Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias. Blood 87, 1900-1911 (1996) (Pubitemid 26068906)
138. M Arsura, CS Hofmann, J Golay, M Introna and GE Sonenshein: A-myb rescues murine B-cell lymphomas from IgM-receptor-mediated apoptosis through c-myc transcriptional regulation. Blood 96, 1013-1020 (2000) (Pubitemid 30616868)
139. RH Chen, S Fields and JS Lipsick: Dissociation of transcriptional activation and oncogenic transformation by v-Myb. Oncogene 11, 1771-1779 (1995)
140. SL Fu and JS Lipsick: FAETL motif required for leukemic transformation by v-Myb. J Virol 70, 5600-5610 (1996) (Pubitemid 26240737)
141. T Nomura, N Sakai, A Sarai, T Sudo, C Kanei-Ishii, RG Ramsay, D Favier, TJ Gonda and S Ishii: Negative autoregulation of c-Myb activity by homodimer formation through the leucine zipper. J Biol Chem 268, 21914-21923 (1993) (Pubitemid 23320696)
142. LH Kasper, F Boussouar, PA Ney, CW Jackson, J Rehg, JM van Deursen and PK Brindle: A transcriptionfactor- binding surface of coactivator p300 is required for haematopoiesis. Nature 419, 738-743 (2002) (Pubitemid 35177961)
143. M Oelgeschläger, R Janknecht, J Krieg, S Schreek and B Lüscher: Interaction of the co-activator CBP with Myb proteins: effects on Myb-specific transcription and on the cooperativity with NF-M. EMBO J 15, 2771-2780 (1996) (Pubitemid 26176254)
144. T Zor, RN De Guzman, HJ Dyson and PE Wright: Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb. J Mol Biol 337, 521-534 (2004) (Pubitemid 38326874)
145. P Dai, H Akimaru, Y Tanaka, D-X Hou, T Yasukawa, C Kanei-Ishii, T Takahashi and S Ishii: CBP as a transcriptional coactivator of c-Myb. Genes Dev 10, 528-540 (1996) (Pubitemid 26091765)
146. D Favier and TJ Gonda: Detection of proteins that bind to the leucine zipper motif of c-Myb. Oncogene 9, 305-311 (1994) (Pubitemid 24020963)
147. Y Sano and S Ishii: Increased affinity of c-Myb for CREB-binding protein (CBP) after CBP-induced acetylation. J Biol Chem 276, 3674-3682 (2001)
148. A Tomita, M Towatari, S Tsuzuki, F Hayakawa, H Kosugi, K Tamai, T Miyazaki, T Kinoshita and H Saito: c- Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300. Oncogene 19, 444-451 (2000) (Pubitemid 30077346)
149. J Bies, S Feikova, DP Bottaro and L Wolff: Hyperphosphorylation and increased proteolytic breakdown of c-Myb induced by the inhibition of Ser/Thr protein phosphatases. Oncogene 19, 2846-2854 (2000) (Pubitemid 30386421)
150. V Matre, O Nordgard, AH Alm-Kristiansen, M Ledsaak and OS Gabrielsen: HIPK1 interacts with c-Myb and modulates its activity through phosphorylation. Biochem Biophys Res Commun 388, 150-154 (2009)
151. E Pani and S Ferrari: p38MAPK delta controls c-Myb degradation in response to stress. Blood Cells Mol Dis 40, 388-394 (2008) (Pubitemid 351508445)
152. O Dahle, TO Andersen, O Nordgard, V Matre, G Del Sal and OS Gabrielsen: Transactivation properties of c- Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner. Eur J Biochem 270, 1338-1348 (2003) (Pubitemid 36384465)
153. Y Morita, C Kanei-Ishii, T Nomura and S Ishii: TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation. Mol Biol Cell 16, 5433-5444 (2005) (Pubitemid 41566851)
154. M Sramko, J Markus, J Kabat, L Wolff and J Bies: Stress-induced inactivation of the c-Myb transcription factor through conjugation of SUMO-2/3 proteins. J Biol Chem 281, 40065-40075 (2006) (Pubitemid 46041812)
155. K Kitagawa, Y Kotake and M Kitagawa: Ubiquitinmediated control of oncogene and tumor suppressor gene products. Cancer Sci 100, 1374-1381 (2009)
156. H Beug, A Leutz, P Kahn and T Graf: Ts mutants of E26 leukemia virus allow transformed myeloblasts, but not erythroblasts or fibroblasts, to differentiate at the nonpermissive temperature. Cell 39, 579-588 (1984) (Pubitemid 15198596)
157. T Graf, A v. Kirchbach and H Beug: Characterization of the hematopoietic target cells of AEV, MC29 and AMV avian leukemia viruses. Exp Cell Res 131, 331-343 (1981) (Pubitemid 11118768)
158. SA Ness, H Beug and T Graf: v-myb dominance over v-myc in doubly transformed chick myelomonocytic cells. Cell 51, 41-50 (1987)
159. C Queva, SA Ness, FA Grasser, T Graf, B Vandenbunder and D Stehelin: Expression patterns of cmyb and of v-myb induced myeloid-1 (mim-1) gene during the development of the chick embryo. Development 114, 125-133 (1992)
160. O Burk, S Mink, M Ringwald and KH Klempnauer: Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors. EMBO J 12, 2027-2038 (1993) (Pubitemid 23157719)
161. SA Ness, E Kowenz-Leutz, T Casini, T Graf and A Leutz: Myb and NF-M: Combinatorial activators of myeloid genes in heterologous cell types. Genes Dev 7, 749-759 (1993) (Pubitemid 23163580)
162. A Leutz, K Damm, E Sterneck, E Kowenz, S Ness, R Frank, H Gausepohl, YC Pan, J Smart, M Hayman and a et: Molecular cloning of the chicken myelomonocytic growth factor (cMGF) reveals relationship to interleukin 6 and granulocyte colony stimulating factor. EMBO J 8, 175-181 (1989) (Pubitemid 19273960)
163. J Frampton, K McNagny, M Sieweke, A Philip, G Smith and T Graf: v-Myb DNA binding is required to block thrombocytic differentiation of Myb-Ets-transformed multipotent haematopoietic progenitors. EMBO J 14, 2866-2875 (1995)
164. T Metz and T Graf: v-myb and v-ets transform chicken erythroid cells and cooperate both in trans and in cis to induce distinct differentiation phenotypes. Genes Dev 5, 369-380 (1991) (Pubitemid 21905960)
165. T Metz and T Graf: Fusion of the nuclear oncoproteins v-Myb and v-Ets is required for the leukemogenicity of E26 virus. Cell 66, 95-105 (1991) (Pubitemid 121001350)
166. N Kraut, J Frampton and T Graf: Rem-1, a putative direct target gene of the Myb-Ets fusion oncoprotein in haematopoietic progenitors, is a member of the recoverin family. Oncogene 10, 1027-1036 (1995)
167. A Hogg, S Schirm, H Nakagoshi, P Bartley, S Ishii, JM Bishop and TJ Gonda: Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2. Oncogene 15, 2885-2898 (1997) (Pubitemid 28008981)
168. P Melotti and B Calabretta: Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb. Blood 87, 2221-2234 (1996) (Pubitemid 26086861)
169. P Melotti, DH Ku and B Calabretta: Regulation of the expression of the hematopoietic stem cell antigen CD34: role of c-myb. J Exp Med 179, 1023-1028 (1994) (Pubitemid 24065662)
170. P Melotti and B Calabretta: Ets-2 and c-Myb act independently in regulating expression of the hematopoietic stem cell antigen CD34. J Biol Chem 269, 25303-25309 (1994) (Pubitemid 24336208)
171. P Melotti and B Calabretta: The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis. Proc Natl Acad Sci U S A 93, 5313-5318 (1996) (Pubitemid 26159446)
172. SA Ness: Myb protein specificity: evidence of a context-specific transcription factor code. Blood Cells Mol Dis 31, 192-200 (2003)
173. B Calabretta, RB Sims, M Valtieri, D Caracciolo, C Szczylik, D Venturelli, M Ratajczak, M Beran and AM Gewirtz: Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of cmyb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. Proc Natl Acad Sci U S A 88, 2351-2355 (1991) (Pubitemid 21916414)
174. YK Lieu and EP Reddy: Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of selfrenewal due to impaired proliferation and accelerated differentiation. Proc Natl Acad Sci U S A 106, 21689-21694 (2009)
175. D Orlic, S Anderson, LG Biesecker, BP Sorrentino and DM Bodine: Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NFE2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Proc Natl Acad Sci U S A 92, 4601-4605 (1995)
176. TY Chu and P Besmer: Characterization of the promoter of the proto-oncogene c-kit. Proceedings of the National Science Council, Republic of China - Part B, Life Sciences 19, 8-18 (1995)
177. DS Krause, ML Mucenski, AM Lawler and WS May: CD34 expression by embryonic hematopoietic and endothelial cells does not require c-Myb. Exp Hematol 26, 1086-1092 (1998) (Pubitemid 28477777)
178. P Papathanasiou, R Tunningley, DR Pattabiraman, P Ye, TJ Gonda, B Whittle, AE Hamilton, SO Cridland, R Lourie and AC Perkins: A recessive screen for genes regulating hematopoietic stem cells. Blood (2010)
179. ML Sandberg, SE Sutton, MT Pletcher, T Wiltshire, LM Tarantino, JB Hogenesch and MP Cooke: c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation. Dev Cell 8, 153-166 (2005) (Pubitemid 40197733)
180. CE Burns, JL Galloway, AC Smith, MD Keefe, TJ Cashman, EJ Paik, EA Mayhall, AH Amsterdam and LI Zon: A genetic screen in zebrafish defines a hierarchical network of pathways required for hematopoietic stem cell emergence. Blood 113, 5776-5782 (2009)
181. K Kissa, E Murayama, A Zapata, A Cortes, E Perret, C Machu and P Herbomel: Live imaging of emerging hematopoietic stem cells and early thymus colonization. Blood 111, 1147-1156 (2008) (Pubitemid 351213395)
182. B Hamilton, Q Feng, M Ye and GG Welstead: Generation of induced pluripotent stem cells by reprogramming mouse embryonic fibroblasts with a four transcription factor, doxycycline inducible lentiviral transduction system. J Vis Exp (2009)
183. A Meissner, M Wernig and R Jaenisch: Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol 25, 1177-1181 (2007) (Pubitemid 47538112)
184. Y Sun, H Li, Y Liu, MP Mattson, MS Rao and M Zhan: Evolutionarily conserved transcriptional coexpression guiding embryonic stem cell differentiation. PLoS One 3, e3406 (2008)
185. M Britos-Bray and AD Friedman: Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c- Myb. Mol Cell Biol 17, 5127-535. (1997)
186. G Lang, JR White, MJ Argent-Katwala, CG Allinson and K Weston: Myb proteins regulate the expression of diverse target genes. Oncogene 24, 1375-1384 (2005) (Pubitemid 40343117)
187. W Lei, F Liu and SA Ness: Positive and Negative Regulation of c-Myb by Cyclin D1, Cyclin-Dependent Kinases and p27 Kip1. Blood 105, 3855-3861 (2005) (Pubitemid 40656128)
188. R Sandoval, M Pilkinton and OR Colamonici: Deletion of the p107/p130-binding domain of Mip130/LIN- 9 bypasses the requirement for CDK4 activity for the dissociation of Mip130/LIN-9 from p107/p130-E2F4 complex. Exp Cell Res 315, 2914-2920 (2009)
189. O Bartsch, S Horstmann, K Toprak, KH Klempnauer and S Ferrari: Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb. Eur J Biochem 260, 384-391 (1999) (Pubitemid 29122533)
190. C Muller-Tidow, W Wang, GE Idos, S Diederichs, R Yang, C Readhead, WE Berdel, H Serve, M Saville, R Watson and HP Koeffler: Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissuespecific regulation of B-myb function. Blood 97, 2091-2097 (2001) (Pubitemid 32239091)
191. P Sinclair, CJ Harrison, M Jarosova and L Foroni: Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36). Haematologica 90, 602-611 (2005) (Pubitemid 40780879)
192. PW Sobieszczuk, TJ Gonda and AR Dunn: Structure and biological activity of the transcriptional initiation sequences of the murine c-myb oncogene. Nucleic Acids Res 17, 9593-9611 (1989) (Pubitemid 20010770)
193. TP Bender, CB Thompson and WM Kuehl: Differential expression of c-myb mRNA in murine B lymphomas by a block to transcription elongation. Science 237, 1473-1476 (1987) (Pubitemid 17136212)
194. A Murati, C Gervais, N Carbuccia, P Finetti, N Cervera, J Adelaide, S Struski, E Lippert, F Mugneret, I Tigaud, D Penther, C Bastard, B Poppe, F Speleman, L Baranger, I Luquet, P Cornillet-Lefebvre, N Nadal, F Nguyen-Khac, C Perot, S Olschwang, F Bertucci, M Chaffanet, M Lessard, MJ Mozziconacci and D Birnbaum: Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases. Leukemia 23, 85-94 (2009)
195. ET Wang, R Sandberg, S Luo, I Khrebtukova, L Zhang, C Mayr, SF Kingsmore, GP Schroth and CB Burge: Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470-476 (2008) (Pubitemid 352759009)
196. GLC Shen-Ong: Alternative internal splicing in c-myb RNAs occurs commonly in normal and tumor cells. EMBO J 6, 4035-4039 (1987)
197. GL Shen-Ong: Alternate forms of myb: consequences of virus insertion in myeloid tumorigenesis and alternative splicing in normal development. Current Topics in Microbiology & Immunology 149, 71-76 (1989)
198. GLC Shen-Ong, B Lüscher and RN Eisenman: A second c-myb protein is translated from an alternatively spliced mRNA expressed from normal and 5′-disrupted myb loci. Mol Cell Biol 9, 5456-5463 (1989) (Pubitemid 20004362)
199. GLC Shen-Ong, RM Skurla Jr., JD Owens and JF Mushinski: Alternative Splicing of RNAs Transcribed from the Human c-myb Gene. Mol Cell Biol 10, 2715-2722 (1990)
200. EH Westin, KM Gorse and MF Clarke: Alternative splicing of the human c-myb gene. Oncogene 5, 1117-1124 (1990)
201. D Rosson, D Dugan and EP Reddy: Aberrant splicing events that are induced by proviral integration: implications for myb oncogene activation. Proc Natl Acad Sci U S A 84, 3171-3175 (1987) (Pubitemid 17085366)
202. GL Shen-Ong, B Luscher and RN Eisenman: A second c-myb protein is translated from an alternatively spliced mRNA expressed from normal and 5′-disrupted myb loci. Mol Cell Biol 9, 5456-5463 (1989) (Pubitemid 20004362)
203. GL Shen-Ong, RMJ Skurla, JD Owens and JF Mushinski: Alternative splicing of RNAs transcribed from the human c-myb gene. Mol Cell Biol 10, 2715-2722 (1990)
204. CH Woo, L Sopchak and JS Lipsick: Overexpression of an alternatively spliced form of c-Myb results in increases in transactivation and transforms avian myelomonoblasts. J Virol 72, 6813-6821 (1998) (Pubitemid 28324001)
205. A Kumar, SJ Baker, CM Lee and EP Reddy: Molecular mechanisms associated with the regulation of apoptosis by the two alternatively spliced products of c- Myb. Mol Cell Biol 23, 6631-6645 (2003) (Pubitemid 37075773)
206. SJ Baker, A Kumar and EP Reddy: p89c-Myb is not required for fetal or adult hematopoiesis. Genesis (2010)
207. R Karni, E de Stanchina, SW Lowe, R Sinha, D Mu and AR Krainer: The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol 14, 185-193 (2007) (Pubitemid 46355578)
208. V Ambros: The functions of animal microRNAs. Nature 431, 350-355 (2004) (Pubitemid 39265675)
209. DP Bartel: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004)
210. P Guglielmelli, L Tozzi, A Pancrazzi, C Bogani, E Antonioli, V Ponziani, G Poli, R Zini, S Ferrari, R Manfredini, A Bosi and AM Vannucchi: MicroRNA expression profile in granulocytes from primary myelofibrosis patients. Exp Hematol 35, 1708-1718 (2007)
211. P Garcia and J Frampton: Hematopoietic lineage commitment: miRNAs add specificity to a widely expressed transcription factor. Dev Cell 14, 815-816 (2008) (Pubitemid 351757207)
212. F Navarro, D Gutman, E Meire, M Caceres, I Rigoutsos, Z Bentwich and J Lieberman: miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood 114, 2181-2192 (2009)